I need help ASAP! Please. And if images are used, please include them as JPEGs. Also, please show work since I am not the smartest in statistics, and I graciously thank you.

Treatment group S Placebo 46 -2.2 0.7 Denosumab, 6 mg 44 -2.0 0.9 Denosumab, 14 mg 44 -2.0 0.8 Denosumab, 30 mg 41 -2.2 0.7 Alendronate 47 -2.0 0.9 Calculate the ANOVA table and the F statistic. Are the differences in mean BMD scores among the 5 groups significant? What does that say about the randomization process for this study?24.36 Did the randomization work? When assigning patients with existing symptoms to various treatments in a clinical trial, it is important to verify that randomization did not, by chance; create uneven groups, with different overall levels of symptom severity. A study of low bone mineral density {BMD} among postmenopausal women randomly assigned subjects to 5 treatment groups. BMD at the lumbar spine was measured at the beginning of the study to assess symptom severity. BMD is expressed as a uniess, standardized value; a negative score indicates a EMD less than the normal healthy average for a population of young women. Here are the summarized EMI} scores for the 5 groups at the beginning of the study